Abstract
The effects of glucocorticoids on cancellous bone remodeling and structure are well documented but there are no reported histomorphometric studies in human cortical bone in glucocorticoid-treated patients. We have performed a histomorphometric analysis of iliac crest cortical bone in 14 patients treated with glucocorticoids, 9 females and 5 males, aged 18 to 48 years (34.1 ± 7 years) (mean ± standard deviation [SD]). The underlying disease was cystic fibrosis in 8 patients; asthma 3; and nephrotic syndrome; Crohn disease and inflammatory pseudotumor of the liver in one patient each. Results were compared with an age-matched control group of 10 premenopausal women and 4 men aged 22 to 38 years (30.1 ± 4.8 years) who were not, howerver matched for underlying disease. Cortical bone indices were assessed by image analysis. Cortical width and area were similar in the two groups. However, cortical porosity, Haversian canal number, and density were higher in patients treated with glucocorticoids compared with controls (8.4 ± 8.9% vs. 5.1 ± 3.9%; P = 0.03) (45.9 ± 23.2 vs. 31.9 ± 24.4; P =0.003) (13.7 ± 9.4 vs. 6.7 ± 3.3/mm2; P = 0.00005). Haversian canal area did not differ significantly between groups. The mean wall width of the osteons, bone formation rate (μm2/μm/day) and mineral apposition rate (μm/day) were lower in treated patients compared to controls (48.8 ± 7.1 μm vs. 59.8 ± 12.9 μm; P = 0.01) (0.056 ± 0.040 vs. 0.095 ± 0.058; P = 0.05) and (0.59 ± 0.12 vs. 0.75 ± 0.11; P = 0.002). The proportion of canals with an eroded surface was lower in the treated compared with the control group, although this difference was not statistically significant. These results demonstrate that cortical porosity is increased in patients treated with long-term glucocorticoid therapy, due mainly to an increase in the number rather than size of Haversian canals. This may be because of increased bone resorption during the early stages of glucocorticoid therapy, in combination with long-term impairment of bone formation. Effects of the underlying disease on bone remodeling may also contributed to these changes and could not be excluded in the present study; since control subjects were not matched in terms of disease status.
Similar content being viewed by others
References
C Cooper C Coupland M Mitchell (1995) ArticleTitleRheumatoid-arthritis, corticosteroid-therapy, and hip fracture Ann Rheuma Dis 54 IssueID1 49–52
IR Reid (1997) ArticleTitleSteroid-induced osteoporosis Osteoporo Int 7 213–216 Occurrence Handle10.1007/BF01622291
DT Villareal R Civilelli C Gennari LV Avioli (1991) ArticleTitleIs there an effective treatment for glucocorticoid-induced osteoporosis Calci Tissue Int 49 IssueID2 141–142
H Cushing (1932) ArticleTitleThe basophil adenomas of pituitary body and their clinical manifestations (pituitary basophilism) Bull Johns Hopkins Hosp 50 137–195
RFJM Laan WCAM Buijs LJTO Erning Particlevan JAM Lemmens (1993) ArticleTitleDifferential effects of glucocorticoids on cortical appendicular and cortical vertebral bone mineral content Calcif Tissue Int 52 5–9 Occurrence Handle10.1007/BF00675619 Occurrence Handle8453505
R Laan P Vanriel LBA Vandeputte L Vanerning MA Vanthof JAM Lemmens (1993) ArticleTitleLow-Dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid-arthritis—a randomized, controlled study Ann Internal Med 119 IssueID10 963–968
BP Lukert LG Raisz (1990) ArticleTitleGlucocorticoid-induced osteoporosis—pathogenesis and management Ann Internal Med 112 IssueID5 352–364
KG Saag R Emekey TJ Schnitzer JP Brown (1998) ArticleTitleAlendronate for the prevention and treatment of glucocorticoid-induced osteoporosis N Eng J Med 339 292–299 Occurrence Handle10.1056/NEJM199807303390502
DM Reid RA Hughes RFJM Laan NA Sacco-Gibson (2000) ArticleTitleEfficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomised trial J Bone Miner Res 15 1006–1013 Occurrence Handle10841169
S Cohen RM Levy M Keller E Boling (1999) ArticleTitleRisedronate therapy prevents corticosteroid-induced bone loss Arthritis Rheum 42 2309–2318 Occurrence Handle10.1002/1529-0131(199911)42:11<2309::AID-ANR8>3.0.CO;2-K Occurrence Handle10555025
TP Staa Particlevan HGM Leufkins C Cooper (2000) ArticleTitleThe epidemiology of corticosteroid-induced osteoporosis Osteoporosis Int 13 777–787 Occurrence Handle10.1007/s001980200108
LD Carbonare ME Arlot PM Chavassieux JP Roux NR Portero PJ Meunier (2001) ArticleTitleComparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis J Bone Miner Res 16 IssueID1 97–103 Occurrence Handle11149495
C Bressot PJ Meunier E Chapuy C Lejeune C Edouard AJ Darby (1979) ArticleTitleHistomorphometric profile, pathophysiology and reversibility of corticosteroid-induced osteoporosis Metab Bone Dis Rel Res 1 303–311 Occurrence Handle10.1016/0221-8747(79)90024-9
DW Dempster MA Arlot PJ Meunier (1983) ArticleTitleMean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis Calcif Tissue Int 35 410–417 Occurrence Handle6616314
DW Dempster (1989) ArticleTitleBone histomorphometry in glucocorticoid -induced osteoporosis J Bone Miner Res 4 IssueID2 137–141 Occurrence Handle2658477
V LoCascio P Ballanti S Milani F Bertoldo C LoCascio EM Zanolin E Bonucci (1998) ArticleTitleA histomorphometric long-term longitudnal study of trabecular bone loss in glucocorticoid-treated patients: prednisone versus Deflazacort Calcif Tissue Int 62 199–204 Occurrence Handle10.1007/s002239900417 Occurrence Handle9501951
RS Weinstein CC Powers AM Parfitt SC Manolagas (2002) ArticleTitlePreservation of osteocyte viability by bisphosphonates contributes to bone strength in glucocorticoid-treated mice independently of BMD: an unappreciated determinant of bone strength J Bone Miner Res 17 1133
RS Weinstein RL Jilka AM Parfitt SC Manolagas (1998) ArticleTitleInhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoid—potential mechanisms of their deleterious effects on bone J Clin Invest 102 IssueID2 274–282 Occurrence Handle9664068
JE Compston K Yamaguchi PI Croucher NJ Garrahan PC Lindsay RW Shaw (1995) ArticleTitleThe effects of gonadotrophin-releasing hormone agonists on illiac crest cancellous bone structure in women with endometriosis Bone 16 IssueID2 261–267 Occurrence Handle10.1016/8756-3282(94)00038-2 Occurrence Handle7756056
S Vedi JE Compston A Webb JR Tighe (1983) ArticleTitleHistomorphometric analysis of dynamic parameters of trabecular bone-formation in the iliac crest of normal British subjects Metab Bone Dis Rel Res 5 IssueID2 69–74 Occurrence Handle10.1016/0221-8747(83)90004-8
S Vedi JE Compston A Webb JR Tighe (1982) ArticleTitleHistomorphometric analysis of bone biopsies from the iliac crest of normal British subjects Metab Bone Dis Rel Res 4 IssueID4 231–236 Occurrence Handle10.1016/0221-8747(82)90032-7
GR Jordan N Loveridge KL Bell J Power N Rushton J Reeve (2000) ArticleTitleSpatial clustering of remodeling osteons in the femoral neck cortex: A cause of weakness in hip fracture? Bone 26 IssueID3 305–313 Occurrence Handle10.1016/S8756-3282(99)00272-0 Occurrence Handle10710006
AM Parfitt MK Drezner FH Glorieux JA Kanis H Malluche PJ Meunier SM Ott RR Recker (1987) ArticleTitlebone histomorphometry—standardization of nomenclature, symbols, and units J Bone Miner Res 2 IssueID6 595–610 Occurrence Handle3455637
S Vedi S Greer SJ Skingle NJ Garrahah M Ninkovic GA Alexander JE Compston (1999) ArticleTitleMechanism of bone loss after liver transplantation: a histomorphometric analysis J Bone Miner Res 14 IssueID2 281–287 Occurrence Handle9933483
E Shane M Rivas DJ McMahon RB Staron SJ Silverberg MJ Seibel D Mancini RE Michler K Aaronson V Addesso SH Lo (1997) ArticleTitleBone loss and turnover after cardiac transplantation J Clin Endocrino Metab 82 1497–1506 Occurrence Handle10.1210/jc.82.5.1497
D Chappard E Legrand MF Basle P Fromont JL Racineux A Rebel M Audran (1996) ArticleTitleAltered trabecular architecture induced by corticosteroids: a bone histomorphometric study J Bone Miner Res 11 IssueID5 676–685 Occurrence Handle9157783
AJ Stellon A Davies JE Compston R Williams (1985) ArticleTitleBone loss in autoimmune chronic active hepatitis on maintenance corticosteroid therapy Gastroenterology 89 IssueID5 1078–1085 Occurrence Handle4043665
SL Elkin S Vedi NJ Garrahan ME Hodson JE Compston (2002) ArticleTitleHistomorphometric analysis of bone biopsies from the iliac crest in adults with cystic fibrois Am. J. Respir Crit Cure 166 1470–1474 Occurrence Handle10.1164/rccm.200206-578OC
PI Croucher S Vedi RJ Motley NJ Garrahan MR Stanton JB Compston (1993) ArticleTitleReduced bone formation in patients with osteoporosis associated with inflammatory bowel disease Osteopors Int 3 236–241 Occurrence Handle10.1007/BF01623826
F Dif C Marty C Baudoin M-C Vernejoul ParticleDe G Levi (2004) ArticleTitleSevere osteopenia in CFTR null mice Bone 35 595–603 Occurrence Handle10.1016/j.bone.2004.05.021 Occurrence Handle15336594
N Lane (2001) ArticleTitleAn update on glucocorticoid-induced osteoporosis Rheum Dis Clin North Am 27 235 Occurrence Handle10.1016/S0889-857X(05)70196-4 Occurrence Handle11285998
S Vedi DW Purdie P Ballard S Bord AC Cooper JE Compston (1999) ArticleTitleBone remodeling and structure in postmenopausal women treated with long-term, high-dose estrogen therapy Osteoporos Int 10 52–58 Occurrence Handle10.1007/s001980050194 Occurrence Handle10501780
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vedi, S., Elkin, S. & Compston, J. A Histomorphometric Study of Cortical Bone of the Iliac Crest in Patients Treated with Glucocorticoids. Calcif Tissue Int 77, 79–83 (2005). https://doi.org/10.1007/s00223-004-0205-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00223-004-0205-y